Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
Uncrowned is a new destination for all things MMA, boxing, wrestling, and more, featuring Ariel Helwani. But injectable medications aren’t right for everyone. That’s where a new wave of oral GLP-1 ...
Liz just wanted to lose the baby weight. Like so many other moms, the 33-year-old was struggling to fit into her clothes postpartum. She considered compounded versions of weight-loss drugs like ...
Serena Williams made headlines during the Super Bowl, but it wasn’t for her tennis skills. The 44-year-old legend appeared in ...
Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results